Advertisement

Reactions Weekly

, Volume 1736, Issue 1, pp 10–10 | Cite as

Latent tuberculosis in ixekizumab clinical trial participants

Clinical study
  • 24 Downloads

Reference

  1. Romiti R, et al. Prevalence and outcome of latent tuberculosis in patients receiving ixekizumab: Integrated safety analysis from 11 clinical trials of patients with plaque psoriasis. British Journal of Dermatology : 4 Jan 2019. Available from: URL: http://doi.org/10.1111/bjd.17604

Copyright information

© Springer Nature Switzerland AG 2019

Personalised recommendations